Brought to you by 
Ev3 gets US rights to Invatec's endovascular devices; ended
31 Jul 2015
Executive Summary
Ev3 (minimally invasive endovascular devices) has agreed to exclusively market and distribute Invatec SRL's (cardiovascular and interventional vascular products) endovascular devices in the US and Puerto Rico.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Terminated
Deal Type
-
Alliance
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ev3 gets US rights to Invatec's endovascular devices; ended
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice